As a Canadian asking how to qualify for psychedelic therapy, you’re likely seeking relief from persistent mental health challenges or chronic pain that traditional treatments haven’t fully addressed. Qualifying for this treatment in Canada involves navigating the landscape of medical assessments, understanding eligibility criteria, and finally finding the right healthcare provider. In this guide, I’ll walk you through the step-by-step process of determining your eligibility for psychedelic therapy, drawing from my experience as a medical professional and researcher in the field of psychedelic-assisted therapy. Whether you’re struggling with treatment-resistant depression, anxiety, PTSD, chronic pain, bipolar disorder, or major depressive disorder, this comprehensive roadmap will help you understand if psychedelic therapy is a viable option for you.
How Does The Psychedelic Work?
The psychedelic is a molecule in the arylcyclohexylamine class that was first synthesized in 1962. Originally developed as an anesthetic, in simple terms it has a unique ability to disconnect the thinking part of the brain from the feeling brain. This property makes it particularly effective in treating mental health conditions at sub-anesthetic doses.
In the brain, psychedelics work by acting on brain receptors related to glutamate, a specific neurotransmitter. Psychedelics work by blocking NMDA glutamate receptors and stimulating AMPA receptors. This action leads to increased neuroplasticity, the ability to form new neural connections and reorganize. These changes can help alleviate symptoms of depression, anxiety, and other mental health disorders, often more rapidly than traditional antidepressants, especially in individuals with treatment-resistant depression.
Conditions Treated with Psychedelic Therapy
Psychedelic therapy has shown promising results in treating a range of mental health conditions. These include treatment-resistant depression, anxiety disorders, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), specific addiction conditions, and eating disorders. Additionally, it has demonstrated effectiveness in managing certain chronic pain conditions.
A notable 2023 study revealed that psychedelic therapy is non-inferior to electroconvulsive therapy (ECT) for treatment-resistant depression. Importantly, psychedelic therapy doesn’t come with the cognitive side effects often associated with ECT, making it an attractive alternative for many patients.
Off-Label Use of Psychedelics in Canada
In Canada, the use of psychedelics for mental health applications is considered “off-label.” This means that while it’s not officially approved for these conditions, healthcare providers can prescribe it based on their professional judgment and growing evidence of its efficacy.
Psychedelic treatment can be administered through various routes, each affecting its bioavailability (the ability of a substance to be absorbed and used by the body). Intravenous (IV) administration offers the highest bioavailability, while oral administration has the lowest.
Legal Status of Psychedelics
In Canada, there is only one legally available psychedelic for medical use and is regulated under Schedule I of the Controlled Drugs and Substances Act. This means it requires a prescription from a licensed healthcare provider. While its primary use has traditionally been as an anesthetic, it’s now successfully being used in much lower doses to help clients overcome a multitude of mental health and pain related conditions.
Qualifying Criteria for Psychedelic Therapy in Canada
Qualifying for psychedelic therapy in Canada involves meeting specific criteria that ensure the treatment is appropriate and safe for you. I’ll guide you through the key factors that healthcare providers should consider when determining eligibility for psychedelic therapy treatment.
Age Requirements
In Canada, psychedelic therapy is typically available for adults aged 18 and older. This age requirement is in place because most research on psychedelics’ effectiveness and safety has been conducted on adult populations. However, in some cases, adolescents may be considered for treatment under special circumstances and with appropriate consent. There have been studies showing low dose psychedelic’s safety and efficacy in adolescent depression. The rates of mental health conditions among adolescents and young adults has been increasing, thought to be due to social media and cellular devices, and novel highly effective treatments would be welcome.
It’s important to note that older adults can also qualify for psychedelic therapy. There’s no upper age limit, but healthcare providers may need to conduct more thorough evaluations for seniors due to potential age-related health concerns.
Diagnosed Mental Health Conditions
As discussed, psychedelic therapy is used for treating certain mental health conditions. To qualify, you need to have a diagnosis of one or more conditions that have shown responsiveness to psychedelic therapy treatment. These often include treatment-resistant depression, anxiety disorders, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), alcohol use disorder, chronic pain and other conditions as the research grows. At Field Trip Health we are undergoing a trial of psychedelic assisted therapy for stimulant use disorder and have more clinical trials underway.
Your healthcare provider will assess the severity and duration of your symptoms, as well as your history of previous treatments. They’ll want to ensure that psychedelic therapy is an appropriate next step in your treatment plan.
Chronic Pain Conditions
Psychedelic therapy has also shown promise in managing certain chronic pain conditions. If you’re suffering from chronic pain that hasn’t responded well to conventional treatments, you might be a candidate for psychedelic therapy. This can include conditions such as fibromyalgia, complex regional pain syndrome (CRPS), and certain types of neuropathic pain.
Your pain specialist or healthcare provider will evaluate the nature and severity of your pain, as well as your previous treatment attempts, to determine if psychedelic therapy could be beneficial for you.
The Qualifying Process for Psychedelic Therapy Treatment
The process of qualifying for psychedelic therapy in Canada involves several steps to ensure it’s the right treatment for you. This evaluation includes consultations, assessments, and informed decision-making. I’ll break down each stage of the qualifying process.
Consultation with a Healthcare Provider
The first step is a consultation with a healthcare provider experienced in psychedelic therapy. During this initial meeting, you’ll discuss your medical history, current symptoms, and previous treatments. It’s important to be open about your experiences with depression, anxiety, or chronic pain to help the provider assess if psychedelic therapy is for you.
The healthcare provider will explain how psychedelic therapy works, its potential benefits, and possible side effects. They’ll also answer any questions you have about the treatment process, helping you make an informed decision about proceeding with the evaluation.
Mental Health Assessment
The next step is a thorough mental health assessment. This evaluation typically involves standardized questionnaires and in-depth discussions about your mental health history. The assessment aims to determine the severity of your symptoms and how they impact your daily life.
For those with treatment-resistant depression, the mental health assessment will review your history with other antidepressants and therapies. This information helps determine if psychedelic therapy is an appropriate next step in your treatment plan.
Physical Health Evaluation
Your consulting health care provider will review your physical health conditions to ensure there are not contraindications that would exclude you from treatment. These include pregnancy, uncontrolled blood pressure issues, psychosis and related conditions like schizophrenia which could exclude you from treatment.
It’s essential to disclose all medications you’re currently taking, including over-the-counter drugs and supplements. Some medications may interact with psychedelics and reduce their efficacy, and your provider needs this information to make safe treatment decisions.
Informed Consent and Treatment Plan
If you’re deemed a suitable candidate for psychedelic therapy, the final step in the qualifying process is obtaining informed consent and developing a treatment plan. Your healthcare provider will thoroughly explain the psychedelic therapy protocol, including the number of sessions, dosage, and administration method.
You’ll have the opportunity to ask questions and express any concerns about the treatment. Once you fully understand the process and agree to proceed, you’ll sign an informed consent form. This document confirms that you’re aware of the potential risks and benefits of psychedelic therapy and are voluntarily choosing to undergo treatment.
Next Steps for Qualifying and Accessing Psychedelic Therapy
Now that you understand the qualifying criteria and process for psychedelic therapy in Canada, it’s time to take concrete steps towards accessing this treatment. I will guide you through finding a provider, preparing for your initial consultation, and understanding the follow-up care process.
Finding a Psychedelic Therapy Clinic or Provider Near You
When evaluating potential providers, consider their experience with psychedelic therapy, their treatment protocols, and patient reviews. It’s important to choose a clinic that aligns with your needs and comfort level. Don’t hesitate to contact multiple providers to compare their approaches and find the best fit for you.
At Field Trip Health, we are committed to continuously refining our protocols based on the latest research to optimize patient outcomes. Given that psychedelic therapy treatment protocols have not yet been standardized, it is crucial to choose a provider who stays at the forefront of scientific advancements.
Preparing for Your Initial Consultation
Once you’ve selected a provider, it’s time to prepare for your initial consultation. Gather all relevant medical records, including your mental health history, previous treatments, and any current medications. Be prepared to discuss your symptoms in detail and how they’ve impacted your life.
During the consultation, ask questions about the psychedelic therapy process, potential side effects, and expected outcomes. This is also an opportunity to discuss any concerns you may have about the treatment. Remember, the more open and honest you are with your provider, the better they can tailor the treatment to your specific needs.
Ongoing Monitoring and Follow-Up Care
Psychedelic therapy is not a one-time treatment but rather a process that requires ongoing monitoring and care. Your provider will likely schedule regular follow-up appointments to assess your progress and adjust the treatment as needed. These appointments are important for maximizing the benefits of psychedelic therapy and addressing any side effects or concerns.
At Field Trip Health, our expert team combines psychedelic treatments with tailored psychotherapy sessions to help you process your experiences and develop effective coping strategies. This integrated approach is proven to provide better results than psychedelic therapy alone.
FAQs
Eligibility for psychedelic therapy in Canada includes adults aged 18 and older with a diagnosis of treatment-resistant depression, including bipolar depression, which means failing at least 2 antidepressant treatments. Other eligible conditions may include PTSD, OCD, anxiety disorders, chronic pain and alcohol use disorder.
Exclusion criteria for psychedelic therapy in Canada include uncontrolled hypertension, conditions for which an increased blood pressure may be dangerous such as unstable coronary artery disease, active substance abuse, pregnancy, psychotic symptoms, active mania, schizophrenia and inability to provide informed consent.
Psychedelic therapy is generally not covered by public health insurance plans like OHIP (ON) or MSP (BC) in Canada. However, some private insurance plans cover the psychotherapy or medication administration portion of treatment, or both. Patients should consult their insurance companies for details as coverage varies by provider and plan.
To start psychedelic therapy in Canada, patients need a consultation from a prescribing healthcare provider. Patients will undergo a full psychiatric evaluation and complete a medical form. If they meet the eligibility criteria, the healthcare provider may prescribe psychedelics with informed consent and schedule treatment.
About the Author
Dr. Mario Nucci MD CCFP is a licensed Family Physician with a passion for mental health and the development of new therapies. He is actively engaged in research with a faculty associate professorship at Northern Ontario School of Medicine, and research collaborations with the University of Ottawa, University of Calgary, Lakehead University, Concordia University and Vancouver Island University.
Dr. Nucci is the founder of Bay and Algoma Health Centre in 2019, a walk-in and addiction medicine clinic. He founded the Canadian Centre for Psychedelic Healing in 2019, now operating as Field Trip Health, providing cutting edge mental health care in Toronto, Montreal, Vancouver, Ottawa, Hamilton, Kitchener-Waterloo, Thunder Bay, Sault Ste. Marie, and at-home.
EN 
FR